Fernwood Investment Management, LLC Agios Pharmaceuticals, Inc. Transaction History

Fernwood Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$44.23 - $57.5 $254,322 - $330,625	-5,750 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $58,117 - $81,445	-1,750 Reduced 23.33%	5,750 $249,000
Q2 2020 Aug 06, 2020	SELL	$34.45 - $53.48 $55,120 - $85,568	-1,600 Reduced 17.58%	7,500 $401,000
Q4 2019 Feb 10, 2020	SELL	$30.08 - $50.59 $159,424 - $268,127	-5,300 Reduced 36.81%	9,100 $435,000
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $12,960 - $19,832	400 Added 2.86%	14,400 $467,000
Q2 2019 Aug 01, 2019	SELL	$46.17 - $68.1 $69,255 - $102,149	-1,500 Reduced 9.68%	14,000 $698,000
Q1 2019 May 06, 2019	SELL	$45.92 - $67.67 $27,552 - $40,602	-600 Reduced 3.73%	15,500 $1.05 Million
Q4 2018 Feb 12, 2019	SELL	$42.73 - $76.53 $386,706 - $692,596	-9,050 Reduced 35.98%	16,100 $742,000
Q1 2018 May 03, 2018	SELL	$59.83 - $86.53 $143,592 - $207,672	-2,400 Reduced 8.71%	25,150 $2.06 Million
Q4 2017 Feb 05, 2018	SELL	$52.12 - $72.33 $15,636 - $21,699	-300 Reduced 1.08%	27,550 $1.58 Million
Q3 2017 Nov 09, 2017	BUY	$54.89 - $67.12 $1.53 Million - $1.87 Million	27,850	27,850 $1.86 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fernwood Investment Management, LLC with notifications on news.